, Tracking Stock Market Picks
Enter Symbol:
Davita Inc. (DVA) [hlAlert]

up 170.75 %

Davita Inc. (DVA) rated Buy

Posted on: Tuesday,  Dec 18, 2007  8:25 AM ET by Oppenheimer

Oppenheimer rated Buy Davita Inc. (NYSE: DVA) on 12/18/2007, when the stock price was $28.31. Since
then, Davita Inc. has gained 170.75% as of 08/27/2015's recent price of $76.65.
If you would have followed this Oppenheimer's recommendation on DVA, you would have gained 170.75% of your investment in 2809 days.

DaVita Inc. is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2008, the Company operated or provided administrative services to 1,449 outpatient dialysis centers located in 43 states and the District of Columbia, serving approximately 112,000 patients. It also provides acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. DaVita Inc?s dialysis and related lab services business accounts for approximately 96% of its consolidated revenues. Other ancillary services and strategic initiatives businesses account for approximately 4% of its consolidated revenues and relate primarily to its core business of providing renal care services. It also provides ancillary services and strategic initiatives, such as infusion therapy services, pharmacy services, vascular access services, disease management services and special needs plans,

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2007 8:25 AM Buy
28.31 32.50
as of 8/27/2015
1 Week down  -2.39 %
1 Month down  -6.03 %
3 Months down  -6.36 %
1 YTD up  20.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2007 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy